The welfare effects of innovative pharmaceuticals: an international perspective from the Dutch experience
Author
Abstract
Suggested Citation
DOI: 10.1080/00036846.2011.628296
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Tomas J. Philipson & Eric Sun, 2008.
"Is the Food And Drug Administration Safe And Effective?,"
Journal of Economic Perspectives, American Economic Association, vol. 22(1), pages 85-102, Winter.
- Tomas J. Philipson & Eric Sun, 2007. "Is the Food and Drug Administration Safe and Effective?," NBER Working Papers 13561, National Bureau of Economic Research, Inc.
- Philipson, Tomas J. & Sun, Eric, 2007. "Is the Food and Drug Administration Safe and Effective?," Working Papers 218, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
- Joshua Cohen & Laura Faden & Susan Predaris & Brian Young, 2007. "Patient access to pharmaceuticals: an international comparison," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(3), pages 253-266, September.
- Groot, Wim & Maassen van den Brink, Henriëtte, 2004. "A direct method for estimating the compensating income variation for severe headache and migraine," Social Science & Medicine, Elsevier, vol. 58(2), pages 305-314, January.
- Frank R. Lichtenberg, 2007.
"Benefits and costs of newer drugs: an update,"
Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 485-490.
- Frank Lichtenberg, 2002. "Benefits and Costs of Newer Drugs: An Update," NBER Working Papers 8996, National Bureau of Economic Research, Inc.
- Pierre-Yves Crémieux & Pierre Ouellette & Patrick Petit, 2007. "Do Drugs Reduce Utilisation of Other Healthcare Resources?," PharmacoEconomics, Springer, vol. 25(3), pages 209-221, March.
- Frank Lichtenberg, 2006. "The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003," PharmacoEconomics, Springer, vol. 24(3), pages 5-25, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Rexford E. Santerre, 2011. "National and International Tests of the New Drug Cost Offset Theory," Southern Economic Journal, John Wiley & Sons, vol. 77(4), pages 1033-1043, April.
- Dusanee Kesavayuth & Robert Rosenman & Vasileios Zikos, 2013. "Does Personality Affect how People Perceive their Health?," Working Papers 2013-13, School of Economic Sciences, Washington State University.
- Ólafsdóttir, Thorhildur & Ásgeirsdóttir, Tinna Laufey & Norton, Edward C., 2020.
"Valuing pain using the subjective well-being method,"
Economics & Human Biology, Elsevier, vol. 37(C).
- Thorhildur Ólafsdóttir & Tinna Laufey Ásgeirsdóttir & Edward C. Norton, 2017. "Valuing Pain using the Subjective Well-being Method," NBER Working Papers 23649, National Bureau of Economic Research, Inc.
- Karine Lamiraud & Stephane Lhuillery, 2016.
"Endogenous Technology Adoption and Medical Costs,"
Health Economics, John Wiley & Sons, Ltd., vol. 25(9), pages 1123-1147, September.
- Lamiraud, Karine & Lhuillery, Stephane, 2015. "Endogenous Technology Adoption and Medical Costs," ESSEC Working Papers WP1518, ESSEC Research Center, ESSEC Business School.
- Karine Lamiraud & Stéphane Lhuillery, 2016. "Endogenous Technology Adoption and Medical Costs," Post-Print hal-01512885, HAL.
- Groot, Wim & Maassen van den Brink, Henriette & van Praag, Bernard M. S., 2006.
"The Compensating Income Variation of Social Capital,"
IZA Discussion Papers
2529, Institute of Labor Economics (IZA).
- Wim Groot & Henriëtte Maassen van den Brink & Bernard M.S. van Praag, 2007. "The Compensating Income Variation of Social Capital," Tinbergen Institute Discussion Papers 07-050/3, Tinbergen Institute.
- Wim Groot & Henriette Maassen van den Brink & Bernard M.S. van Praag, 2007. "The Compensating Income Variation of Social Capital," CESifo Working Paper Series 1889, CESifo.
- Stolpe, Michael, 2003. "Ressourcen und Ergebnisse der globalen Gesundheitsökonomie: Einführung und Überblick," Kiel Working Papers 1177, Kiel Institute for the World Economy (IfW Kiel).
- Howley, Peter, 2017. "Less money or better health? Evaluating individual’s willingness to make trade-offs using life satisfaction data," Journal of Economic Behavior & Organization, Elsevier, vol. 135(C), pages 53-65.
- Verniers, Isabel & Stremersch, Stefan & Croux, Christophe, 2011. "The global entry of new pharmaceuticals: A joint investigation of launch window and price," International Journal of Research in Marketing, Elsevier, vol. 28(4), pages 295-308.
- Michel Bordo & John Lando-Lane, 2013. "Does Expansionary Monetary Policy Cause Asset Price Booms? Some Historical and Empirical Evidence," Working Papers Central Bank of Chile 710, Central Bank of Chile.
- Claude Montmarquette & Stéphanie Boulenger & Joanne Castonguay, 2014. "Les risques liés à la création de PHARMA-QUEBEC," CIRANO Project Reports 2014rp-05, CIRANO.
- Tomas J. Philipson & Eric Sun & Dana Goldman, 2010.
"The Effects of Product Liability Exemption in the Presence of the FDA,"
NBER Chapters, in: Regulation vs. Litigation: Perspectives from Economics and Law, pages 137-163,
National Bureau of Economic Research, Inc.
- Tomas J. Philipson & Eric C. Sun & Dana Goldman, 2009. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Working Papers 15603, National Bureau of Economic Research, Inc.
- Brad R. Humphreys & Bruce K. Johnson & John C. Whitehead, 2020.
"Validity and reliability of contingent valuation and life satisfaction measures of welfare: An application to the value of national Olympic success,"
Southern Economic Journal, John Wiley & Sons, vol. 87(1), pages 316-330, July.
- Brad R. Humphreys & Bruce K. Johnson & John C. Whitehead, 2017. "Validity and Reliability of Contingent Valuation and Life Satisfaction Measures of Welfare: An Application to the Value of National Olympic Success," Working Papers 17-08, Department of Economics, Appalachian State University.
- Baldursdottir, Kristjana & Asgeirsdottir, Tinna Laufey & Olafsdottir, Thorhildur, 2023. "How sensitive is the compensating income variation to severity and adaptation?," Economics & Human Biology, Elsevier, vol. 49(C).
- Law, Michael R. & Grépin, Karen A., 2010. "Is newer always better? Re-evaluating the benefits of newer pharmaceuticals," Journal of Health Economics, Elsevier, vol. 29(5), pages 743-750, September.
- Immordino, Giovanni & Pagano, Marco & Polo, Michele, 2011.
"Incentives to innovate and social harm: Laissez-faire, authorization or penalties?,"
Journal of Public Economics, Elsevier, vol. 95(7), pages 864-876.
- Immordino, Giovanni & Pagano, Marco & Polo, Michele, 2011. "Incentives to innovate and social harm: Laissez-faire, authorization or penalties?," Journal of Public Economics, Elsevier, vol. 95(7-8), pages 864-876, August.
- Pagano, Marco & Polo, Michele & Immordino, Giovanni, 2009. "Incentives to Innovate and Social Harm: Laissez-Faire, Authorization or Penalties?," CEPR Discussion Papers 7280, C.E.P.R. Discussion Papers.
- Giovanni Immordino & Marco Pagano & Michele Polo, 2009. "Incentives to Innovate and Social Harm:Laissez-Faire, Authorization or Penalties?," Working Papers 349, IGIER (Innocenzo Gasparini Institute for Economic Research), Bocconi University.
- Giovanni Immordino & Marco Pagano & Michele Polo, 2009. "Incentives to Innovate and Social Harm: Laissez-Faire, Authorization or Penalties?," CSEF Working Papers 220, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy.
- Alvin Headen, 2006. "Medicaid Preferred Drug Lists: Cost Containment and Side Effects," PharmacoEconomics, Springer, vol. 24(3), pages 1-3, December.
- Giovanni Immordino & Michele Polo, 2014.
"Public Policies in Investment-Intensive Industries,"
World Scientific Book Chapters, in: Martin Peitz & Yossi Spiegel (ed.), THE ANALYSIS OF COMPETITION POLICY AND SECTORAL REGULATION, chapter 13, pages 365-388,
World Scientific Publishing Co. Pte. Ltd..
- Giovanni Immordino & Michele Polo, 2013. "Public Policies in Investment Intensive Industries," IEFE Working Papers 59, IEFE, Center for Research on Energy and Environmental Economics and Policy, Universita' Bocconi, Milano, Italy.
- Giovanni Immordino & Michele Polo, 2013. "Public Policies in Investment Intensive Industries," Working Papers 507, IGIER (Innocenzo Gasparini Institute for Economic Research), Bocconi University.
- Carl Blankart & Tom Stargardt & Jonas Schreyögg, 2011. "Availability of and Access to Orphan Drugs," PharmacoEconomics, Springer, vol. 29(1), pages 63-82, January.
- Michael D. Bordo & John Landon-Lane, 2014.
"Does Expansionary Monetary Policy Cause Asset Price Booms? Some Historical and Empirical Evidence,"
Central Banking, Analysis, and Economic Policies Book Series, in: Sofía Bauducco & Lawrence Christiano & Claudio Raddatz (ed.),Macroeconomic and Financial Stability: challenges for Monetary Policy, edition 1, volume 19, chapter 3, pages 61-116,
Central Bank of Chile.
- Michael D. Bordo & John Landon-Lane, 2013. "Does expansionary monetary policy cause asset price booms? some historical and empirical evidence," Journal Economía Chilena (The Chilean Economy), Central Bank of Chile, vol. 16(2), pages 04-52, August.
- Michael D. Bordo & John Landon-Lane, 2013. "Does Expansionary Monetary Policy Cause Asset Price Booms; Some Historical and Empirical Evidence," NBER Working Papers 19585, National Bureau of Economic Research, Inc.
- Tomas J. Philipson & George Zanjani, 2013. "Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension," NBER Working Papers 19005, National Bureau of Economic Research, Inc.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:applec:45:y:2013:i:9:p:1219-1226. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/RAEC20 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.